DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer

Despite the advantages of neoadjuvant chemotherapy (NACT), associated toxicity is a serious complication that renders monitoring of the patients’ response to NACT highly important. Thus, prediction of tumor response to treatment is imperative to avoid exposure of potential non-responders to deleteri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Sigin, Vladimir O., Kalinkin, Alexey I., Kuznetsova, Ekaterina B., Simonova, Olga A., Chesnokova, Galina G., Litviakov, Nikolai V., Slonimskaya, Elena M., Tsyganov, Matvey M., Ibragimova, Marina K., Volodin, Ilya V., Vinogradov, Ilya I., Vinogradov, Maksim I., Vinogradov, Igor Y., Kutsev, Sergey I., Strelnikov, Vladimir V., Zaletaev, Dmitry V., Tanas, Alexander S.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7280523/
https://ncbi.nlm.nih.gov/pubmed/32514046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-66197-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados